BrainStorm Cell Therapeutics
BCLI
#10388
Rank
A$8.89 M
Marketcap
A$0.81
Share price
5.52%
Change (1 day)
-70.63%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2025 (TTM): A-$2.26

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.11. In 2015 the company made an earnings per share (EPS) of A-$9.54 an increase over its 2014 EPS that were of A-$14.42.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$2.26
2015A-$9.54-33.82%
2014A-$14.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
A$15.53-837.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.22-537.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A-$5.67 169.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A-$8.89 322.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A-$4.40 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA